| Autor: |
Lalonde, Robert L., Nicolas, Hannah A., Cutler, Rowan S., Pantekidis, Irene, Zhang, Weibo, Yelick, Pamela C. |
| Předmět: |
|
| Zdroj: |
Developmental Dynamics; May2023, Vol. 252 Issue 5, p605-628, 24p |
| Abstrakt: |
Background: Fibrodysplasia ossificans progressiva (FOP), a rare disease characterized by progressive heterotopic ossification of muscle and connective tissues, is caused by autosomal dominant activating mutations in the type I receptor, ACVR1/ALK2. The classic human FOP variant, ACVR1R206H, shows increased bone morphogenetic protein (BMP) signaling and activation by activins. Results: Here, we performed in vivo functional characterization of human ACVR1R206H and orthologous zebrafish Acvr1lR203H using early embryonic zebrafish dorsoventral patterning as a phenotypic readout for receptor activity. Our results showed that human ACVR1R206H and zebrafish Acvr1lR203H exhibit functional differences in early embryonic zebrafish, and that human ACVR1R206H retained its signaling activity in the absence of a ligand‐binding domain (LBD). We also showed, for the first time, that zebrafish Acvr2ba/Acvr2bb receptors are required for human ACVR1R206H signaling in early embryonic zebrafish. Conclusions: Together, these data provide new insight into ACVR1R206H signaling pathways that may facilitate the design of new and effective therapies for FOP patients. Key Findings: Human ACVR1‐R206H mediates upregulated BMP signaling in embryonic zebrafish.The orthologous zebrafish Acvr1l‐R203H variant does not exhibit upregulated BMP signaling.Zebrafish Acvr2ba/Acvr2bb is required for human ACVR1‐R206H signaling in embryonic zebrafish. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text